Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2004-9-9
pubmed:abstractText
The purpose of this research was to determine whether estrogen receptor alpha specifically phosphorylated at Ser(118) is associated with clinical outcome in primary breast tumors from estrogen receptor-positive and node-negative breast cancer patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5902-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15355923-Antineoplastic Agents, Hormonal, pubmed-meshheading:15355923-Breast Neoplasms, pubmed-meshheading:15355923-Disease-Free Survival, pubmed-meshheading:15355923-Estrogen Receptor alpha, pubmed-meshheading:15355923-Female, pubmed-meshheading:15355923-Humans, pubmed-meshheading:15355923-Ligands, pubmed-meshheading:15355923-Male, pubmed-meshheading:15355923-Middle Aged, pubmed-meshheading:15355923-Neoadjuvant Therapy, pubmed-meshheading:15355923-Neoplasm Invasiveness, pubmed-meshheading:15355923-Phosphorylation, pubmed-meshheading:15355923-Protein Binding, pubmed-meshheading:15355923-Receptors, Progesterone, pubmed-meshheading:15355923-Serine, pubmed-meshheading:15355923-Survival Rate, pubmed-meshheading:15355923-Tamoxifen, pubmed-meshheading:15355923-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.
pubmed:affiliation
Manitoba Institute of Cell Biology, Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada. lcmurph@cc.umanitoba.ca
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't